Literature DB >> 16418338

Kinetics of penetration influence the apparent potency of vanilloids on TRPV1.

Jozsef Lazar1, Derek C Braun, Attila Tóth, Yun Wang, Larry V Pearce, Vladimir A Pavlyukovets, Peter M Blumberg, Susan H Garfield, Stephen Wincovitch, Hyun-Kyung Choi, Jeewoo Lee.   

Abstract

Evidence that the ligand binding site of TRPV1 lies on the inner face of the plasma membrane and that much of the TRPV1 itself is localized to internal membranes suggests that the rate of ligand entry into the cell may be an important determinant of the kinetics of ligand action. In this study, we synthesized a BODIPY TR-labeled fluorescent capsaicin analog (CHK-884) so that we could directly measure ligand entry. We report that CHK-884 penetrated only slowly into Chinese hamster ovary (CHO) cells expressing rat TRPV1, with a t1/2 of 30 +/- 4 min, and localized in the endoplasmic reticulum and Golgi. Although CHK-884 was only weakly potent for TRPV1 binding (Ki = 6400 +/- 230 nM), it was appreciably more potent when assayed by intracellular calcium imaging and was 3.2-fold more potent with a 1-h incubation time (37 nM) than with a 5-min incubation time. Olvanil, a highly lipophilic vanilloid, yielded an EC50 of 4.3 nM upon intracellular calcium imaging with an incubation time of 1 h, compared with an EC50 value of 29.5 nM for calcium imaging assayed at 5 min. Likewise, the antagonist 5-iodo-resiniferatoxin (5-iodo-RTX) displayed a Ki of 4.2 pM if incubated with CHO-TRPV1 cells for 2 h before addition of capsaicin compared with 1.5 nM if added simultaneously. We conclude that some vanilloids may have slow kinetics of uptake; this slow uptake may affect assessment of structure activity relations and may represent a significant factor for vanilloid drug design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418338     DOI: 10.1124/mol.105.019158

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Differential modulation of agonist and antagonist structure activity relations for rat TRPV1 by cyclosporin A and other protein phosphatase inhibitors.

Authors:  Larry V Pearce; Attila Toth; HyungChul Ryu; Dong Wook Kang; Hyun-Kyung Choi; Mi-Kyoung Jin; Jeewoo Lee; Peter M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-08       Impact factor: 3.000

2.  Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels.

Authors:  Luciano De Petrocellis; Aniello Schiano Moriello; Gabriele Fontana; Alessandro Sacchetti; Daniele Passarella; Giovanni Appendino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

3.  TRPV1 is a novel target for omega-3 polyunsaturated fatty acids.

Authors:  José A Matta; Rosa L Miyares; Gerard P Ahern
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

Review 4.  TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation.

Authors:  Peter M Blumberg; Larry V Pearce; Jeewoo Lee
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

5.  N-methyl-substituted fluorescent DAG-indololactone isomers exhibit dramatic differences in membrane interactions and biological activity.

Authors:  Noga Gal; Sofiya Kolusheva; Noemi Kedei; Andrea Telek; Taiyabah A Naeem; Nancy E Lewin; Langston Lim; Poonam Mannan; Susan H Garfield; Saïd El Kazzouli; Dina M Sigano; Victor E Marquez; Peter M Blumberg; Raz Jelinek
Journal:  Chembiochem       Date:  2011-10-17       Impact factor: 3.164

6.  Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1).

Authors:  Larry V Pearce; Jihyae Ann; Aeran Jung; Shivaji A Thorat; Brienna K A Herold; Amelework D Habtemichael; Peter M Blumberg; Jeewoo Lee
Journal:  J Med Chem       Date:  2017-09-21       Impact factor: 7.446

Review 7.  Vanilloid-induced conduction analgesia: selective, dose-dependent, long-lasting, with a low level of potential neurotoxicity.

Authors:  Igor Kissin
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

8.  Photoswitchable fatty acids enable optical control of TRPV1.

Authors:  James Allen Frank; Mirko Moroni; Rabih Moshourab; Martin Sumser; Gary R Lewin; Dirk Trauner
Journal:  Nat Commun       Date:  2015-05-22       Impact factor: 14.919

9.  Capsaicin interaction with TRPV1 channels in a lipid bilayer: molecular dynamics simulation.

Authors:  Sonya M Hanson; Simon Newstead; Kenton J Swartz; Mark S P Sansom
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

10.  Kunitz-Type Peptide HCRG21 from the Sea Anemone Heteractis crispa Is a Full Antagonist of the TRPV1 Receptor.

Authors:  Margarita Monastyrnaya; Steve Peigneur; Elena Zelepuga; Oksana Sintsova; Irina Gladkikh; Elena Leychenko; Marina Isaeva; Jan Tytgat; Emma Kozlovskaya
Journal:  Mar Drugs       Date:  2016-12-15       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.